Repatha is available as a 140mg/mL single-use prefilled syringe, a 140mg/mL single-use prefilled SureClick autoinjector, and the 420mg/3.5mL single-use Pushtronex system. For more information call ...

Repatha is a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor. Amgen has announced a price reduction for Repatha (evolocumab), bringing the list price of the therapy to $5,850 per ...

The U.S. Food and Drug Administration on Thursday approved Amgen Inc's drug Repatha for patients with hereditary forms of high cholesterol and those at high risk of cardiovascular disease.